
Milestone Pharmaceuticals MIST
$ 1.21
-3.97%
Annual report 2025
added 03-20-2026
Milestone Pharmaceuticals PEG Ratio 2011-2026 | MIST
Annual PEG Ratio Milestone Pharmaceuticals
| 2025 | 2024 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.102 | 0.0885 | - | -0.244 | 0.0245 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.102 | -0.244 | -0.00737 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | ||
|
Anika Therapeutics
ANIK
|
-0.431 | $ 14.21 | -0.42 % | $ 208 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | ||
|
Altimmune
ALT
|
0.649 | $ 3.35 | -2.62 % | $ 295 M | ||
|
Ascendis Pharma A/S
ASND
|
-0.767 | $ 216.26 | -0.83 % | $ 5 B | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 19.12 | -0.57 % | $ 894 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
0.158 | $ 0.62 | 2.14 % | $ 7.1 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 46.45 | -0.91 % | $ 4.18 B | ||
|
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.0906 | $ 1.4 | -0.36 % | $ 357 M | ||
|
Exelixis
EXEL
|
-2.14 | $ 41.13 | -0.69 % | $ 11.2 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
ChemoCentryx
CCXI
|
-0 | - | - | $ 3.74 B | ||
|
Aytu BioScience
AYTU
|
-0.00324 | $ 2.63 | - | $ 16.5 M | ||
|
Fulcrum Therapeutics
FULC
|
-0 | $ 6.64 | -3.63 % | $ 421 K | ||
|
Atreca
BCEL
|
0.187 | - | -11.76 % | $ 5.79 M | ||
|
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | ||
|
Genmab A/S
GMAB
|
0.277 | $ 25.59 | -0.35 % | $ 16.5 B | ||
|
Grifols, S.A.
GRFS
|
-0.077 | $ 7.64 | -0.72 % | $ 6.83 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B | ||
|
Halozyme Therapeutics
HALO
|
0.872 | $ 61.68 | -1.88 % | $ 7.39 B | ||
|
Harmony Biosciences Holdings
HRMY
|
0.631 | $ 26.99 | -2.21 % | $ 1.55 B | ||
|
Bellerophon Therapeutics
BLPH
|
0.0308 | - | -74.18 % | $ 955 K | ||
|
ImmuCell Corporation
ICCC
|
0.0444 | $ 6.43 | 0.31 % | $ 52.5 M | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
Immatics N.V.
IMTX
|
2.14 K | $ 9.32 | -2.0 % | $ 586 M | ||
|
Ionis Pharmaceuticals
IONS
|
-0.108 | $ 69.48 | -1.85 % | $ 11.1 B | ||
|
Innate Pharma S.A.
IPHA
|
-0.0174 | $ 1.33 | -2.92 % | $ 235 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
1.34 | $ 4.29 | -2.94 % | $ 822 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
AIkido Pharma
AIKI
|
-0.000777 | - | 1.93 % | $ 17.4 M |